Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter D Schellinger

Showing results (21-30 of 191) with videos related to

Pageof 20
Sort By:
Stroke|August 5, 2006
Intra-arterial thrombolysis is the treatment of choice for basilar thrombosis: proPeter D Schellinger, Werner Hacke
Stroke|December 17, 2009
Recanalization devices should be restricted to clinical trials: pro (kind of)Peter D Schellinger, Werner Hacke
Neurology|January 2, 2024
Distinguishing Transient Cerebral Ischemia From Other Brief Neurologic EventsSteven Warach, Peter D Schellinger
Stroke|June 17, 2017
Another Enchantment From ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study): Are Savings and Safety More Salutary Than Efficacy?Peter D Schellinger, Georgios Tsivgoulis
Neurocritical Care|September 22, 2005
Intracranial hemorrhage: the role of magnetic resonance imagingPeter D Schellinger, Jochen B Fiebach
Stroke|June 6, 2009
MR mismatch is useful for patient selection for thrombolysis: yesJochen B Fiebach, Peter D Schellinger
Stroke|July 19, 2008
Establishing final infarct volume: stroke lesion evolution past 30 days is insignificantPeter D Schellinger, Jochen B Fiebach
Stroke|October 26, 2018
Endovascular Stroke Therapy in the Late Time WindowPeter D Schellinger, Bart M Demaerschalk
Stroke|March 26, 2005
Perfusion-weighted imaging/diffusion-weighted imaging mismatch on MRI can now be used to select patients for recombinant tissue plasminogen activator beyond 3 hours: proPeter D Schellinger, Jochen B Fiebach
Journal of Stroke|July 9, 2020
Recurrent and Drastic Increase in Dabigatran Levels May Be Induced by Therapeutic Plasma ExchangeMarc A Pflug, Peter D Schellinger
Pageof 20

Showing results (21-30 of 191) with videos related to

Sort By:
Pageof 20
Stroke|August 5, 2006
Intra-arterial thrombolysis is the treatment of choice for basilar thrombosis: proPeter D Schellinger, Werner Hacke
Stroke|December 17, 2009
Recanalization devices should be restricted to clinical trials: pro (kind of)Peter D Schellinger, Werner Hacke
Neurology|January 2, 2024
Distinguishing Transient Cerebral Ischemia From Other Brief Neurologic EventsSteven Warach, Peter D Schellinger
Stroke|June 17, 2017
Another Enchantment From ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study): Are Savings and Safety More Salutary Than Efficacy?Peter D Schellinger, Georgios Tsivgoulis
Neurocritical Care|September 22, 2005
Intracranial hemorrhage: the role of magnetic resonance imagingPeter D Schellinger, Jochen B Fiebach
Stroke|June 6, 2009
MR mismatch is useful for patient selection for thrombolysis: yesJochen B Fiebach, Peter D Schellinger
Stroke|July 19, 2008
Establishing final infarct volume: stroke lesion evolution past 30 days is insignificantPeter D Schellinger, Jochen B Fiebach
Stroke|October 26, 2018
Endovascular Stroke Therapy in the Late Time WindowPeter D Schellinger, Bart M Demaerschalk
Stroke|March 26, 2005
Perfusion-weighted imaging/diffusion-weighted imaging mismatch on MRI can now be used to select patients for recombinant tissue plasminogen activator beyond 3 hours: proPeter D Schellinger, Jochen B Fiebach
Journal of Stroke|July 9, 2020
Recurrent and Drastic Increase in Dabigatran Levels May Be Induced by Therapeutic Plasma ExchangeMarc A Pflug, Peter D Schellinger
Pageof 20